P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Pediatrix Medical Group news
21.06.2022
Mednax will change its name to Pediatrix Medical Group effective July 1, 2022. Mednax common stock will continue to trade on the NYSE under its current ticker symbol MD.
Source: mednax.gcs-web.com
28.04.2022
MEDNAX's GAAP loss for 3 months of 2022 was $21.192 million, compared to a profit of $17.634 million in the previous year. Revenue increased 7.9% to $482.229 million from $446.753 million a year earlier.
Source: mednax.gcs-web.com
17.02.2022
MEDNAX's GAAP net income for 2021 was $130.937 million, compared to a loss of $796.488 million in the previous year. Revenue increased 10.2% to $1.911 billion from $1.734 billion a year earlier.
Source: mednax.gcs-web.com
28.10.2021
MEDNAX reported a GAAP net profit of $83.427 million for 9M 2021, compared to a loss of $732.192 million in the previous year. Revenues increased by 7.3% to $1.413 billion from $1.317 billion a year earlier.
Source: mednax.gcs-web.com
General information
| Company name | Pediatrix Medical Group |
|---|---|
| Sector | Health Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services |
| Business address | 1301 CONCORD TERRACE SUNRISE FL 33323 9543840175 |
| Mailing address | 1301 CONCORD TERRACE SUNRISE FL 33323 |
| Website | www.mednax.com |
| Information disclosure | www.sec.gov |
English (US) 